Cibc Private Wealth Group, LLC Guardant Health, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 244 shares of GH stock, worth $10,833. This represents 0.0% of its overall portfolio holdings.
Number of Shares
244
Previous 544
55.15%
Holding current value
$10,833
Previous $15,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GH
# of Institutions
333Shares Held
128MCall Options Held
843KPut Options Held
2.37M-
Vanguard Group Inc Valley Forge, PA12.1MShares$535 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$499 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$450 Million0.04% of portfolio
-
Cadian Capital Management, LP New York, NY6.93MShares$308 Million8.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$266 Million5.07% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.54B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...